CMPS

Compass Pathways Plc

1 day chart

About CMPS

COMPASS Pathways plc is a United Kingdom-based mental healthcare company. The Company is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression (TRD). The Company has developed COMP360, which is a psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin. The Company's COMP360 has completed a Phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America. This trial assessed the safety and efficacy of COMP360 psilocybin therapy in three doses: 1mg, 10mg, 25mg. The Company is also running a Phase II clinical trial of COMP360 psilocybin therapy for anorexia nervosa and post-traumatic stress disorder (PTSD). The Company is also developing its investigational COMP360 psilocybin therapy for the treatment of a range of mental health conditions, with an initial focus on TRD.

Buy US stocks in Australia starting with CMPS. Open an account and start investing today!

Market Capitalisation

$359.50M

Price-earnings ratio

Dividend yield

0.00%

Volume

9.42K

High today

$7.87

Low today

$7.74

Open price

$7.86

52-week high

$21.50

52-week low

$6.97

CMPS FAQs

Can I buy CMPS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CMPS shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Compass Pathways Plc?

One share of Compass Pathways Plc is valued at $7.77.

What is the ticker symbol for Compass Pathways Plc?

The ticker symbol for Compass Pathways Plc is CMPS.

How do I buy CMPS shares in Australia?

To buy CMPS stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in CMPS

What is the 52-week high for Compass Pathways Plc stock?

The Compass Pathways Plc 52-week high stock price is $21.50.

What is the 52-week low for Compass Pathways Plc stock?

The Compass Pathways Plc 52-week low stock price is $6.97.

What is the market capitalisation of Compass Pathways Plc CMPS?

As of 05/06/2023 Compass Pathways Plc has a market cap of $359M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.